Literature DB >> 33397283

Exploring protocol bias in airway microbiome studies: one versus two PCR steps and 16S rRNA gene region V3 V4 versus V4.

Christine Drengenes1,2, Tomas M L Eagan3,4, Ingvild Haaland3,4, Harald G Wiker4,5, Rune Nielsen3,4.   

Abstract

BACKGROUND: Studies on the airway microbiome have been performed using a wide range of laboratory protocols for high-throughput sequencing of the bacterial 16S ribosomal RNA (16S rRNA) gene. We sought to determine the impact of number of polymerase chain reaction (PCR) steps (1- or 2- steps) and choice of target marker gene region (V3 V4 and V4) on the presentation of the upper and lower airway microbiome. Our analyses included lllumina MiSeq sequencing following three setups: Setup 1 (2-step PCR; V3 V4 region), Setup 2 (2-step PCR; V4 region), Setup 3 (1-step PCR; V4 region). Samples included oral wash, protected specimen brushes and protected bronchoalveolar lavage (healthy and obstructive lung disease), and negative controls.
RESULTS: The number of sequences and amplicon sequence variants (ASV) decreased in order setup1 > setup2 > setup3. This trend appeared to be associated with an increased taxonomic resolution when sequencing the V3 V4 region (setup 1) and an increased number of small ASVs in setups 1 and 2. The latter was considered a result of contamination in the two-step PCR protocols as well as sequencing across multiple runs (setup 1). Although genera Streptococcus, Prevotella, Veillonella and Rothia dominated, differences in relative abundance were observed across all setups. Analyses of beta-diversity revealed that while oral wash samples (high biomass) clustered together regardless of number of PCR steps, samples from the lungs (low biomass) separated. The removal of contaminants identified using the Decontam package in R, did not resolve differences in results between sequencing setups.
CONCLUSIONS: Differences in number of PCR steps will have an impact of final bacterial community descriptions, and more so for samples of low bacterial load. Our findings could not be explained by differences in contamination levels alone, and more research is needed to understand how variations in PCR-setups and reagents may be contributing to the observed protocol bias.

Entities:  

Keywords:  16S rRNA gene; Contamination; Low biomass; Microbiota; Respiratory

Mesh:

Substances:

Year:  2021        PMID: 33397283      PMCID: PMC7784388          DOI: 10.1186/s12864-020-07252-z

Source DB:  PubMed          Journal:  BMC Genomics        ISSN: 1471-2164            Impact factor:   3.969


  38 in total

1.  Comparison of species richness estimates obtained using nearly complete fragments and simulated pyrosequencing-generated fragments in 16S rRNA gene-based environmental surveys.

Authors:  Noha Youssef; Cody S Sheik; Lee R Krumholz; Fares Z Najar; Bruce A Roe; Mostafa S Elshahed
Journal:  Appl Environ Microbiol       Date:  2009-06-26       Impact factor: 4.792

2.  Barcoded primers used in multiplex amplicon pyrosequencing bias amplification.

Authors:  David Berry; Karim Ben Mahfoudh; Michael Wagner; Alexander Loy
Journal:  Appl Environ Microbiol       Date:  2011-09-02       Impact factor: 4.792

3.  Effect of PCR template concentration on the composition and distribution of total community 16S rDNA clone libraries.

Authors:  D P Chandler; J K Fredrickson; F J Brockman
Journal:  Mol Ecol       Date:  1997-05       Impact factor: 6.185

4.  Analysis of culture-dependent versus culture-independent techniques for identification of bacteria in clinically obtained bronchoalveolar lavage fluid.

Authors:  Robert P Dickson; John R Erb-Downward; Hallie C Prescott; Fernando J Martinez; Jeffrey L Curtis; Vibha N Lama; Gary B Huffnagle
Journal:  J Clin Microbiol       Date:  2014-07-30       Impact factor: 5.948

5.  Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers.

Authors:  G G Einarsson; D M Comer; L McIlreavey; J Parkhill; M Ennis; M M Tunney; J S Elborn
Journal:  Thorax       Date:  2016-05-04       Impact factor: 9.139

6.  Multicenter Comparison of Lung and Oral Microbiomes of HIV-infected and HIV-uninfected Individuals.

Authors:  James M Beck; Patrick D Schloss; Arvind Venkataraman; Homer Twigg; Kathleen A Jablonski; Frederic D Bushman; Thomas B Campbell; Emily S Charlson; Ronald G Collman; Kristina Crothers; Jeffrey L Curtis; Kimberly L Drews; Sonia C Flores; Andrew P Fontenot; Mary A Foulkes; Ian Frank; Elodie Ghedin; Laurence Huang; Susan V Lynch; Alison Morris; Brent E Palmer; Thomas M Schmidt; Erica Sodergren; George M Weinstock; Vincent B Young
Journal:  Am J Respir Crit Care Med       Date:  2015-12-01       Impact factor: 21.405

7.  The lung tissue microbiota of mild and moderate chronic obstructive pulmonary disease.

Authors:  Alexa A Pragman; Tianmeng Lyu; Joshua A Baller; Trevor J Gould; Rosemary F Kelly; Cavan S Reilly; Richard E Isaacson; Chris H Wendt
Journal:  Microbiome       Date:  2018-01-09       Impact factor: 14.650

8.  Widespread colonization of the lung by Tropheryma whipplei in HIV infection.

Authors:  Catherine Lozupone; Adela Cota-Gomez; Brent E Palmer; Derek J Linderman; Emily S Charlson; Erica Sodergren; Makedonka Mitreva; Sahar Abubucker; John Martin; Guohui Yao; Thomas B Campbell; Sonia C Flores; Gail Ackerman; Jesse Stombaugh; Luke Ursell; James M Beck; Jeffrey L Curtis; Vincent B Young; Susan V Lynch; Laurence Huang; George M Weinstock; Kenneth S Knox; Homer Twigg; Alison Morris; Elodie Ghedin; Frederic D Bushman; Ronald G Collman; Rob Knight; Andrew P Fontenot
Journal:  Am J Respir Crit Care Med       Date:  2013-05-15       Impact factor: 21.405

9.  The lung microbiome in moderate and severe chronic obstructive pulmonary disease.

Authors:  Alexa A Pragman; Hyeun Bum Kim; Cavan S Reilly; Christine Wendt; Richard E Isaacson
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

10.  Short pyrosequencing reads suffice for accurate microbial community analysis.

Authors:  Zongzhi Liu; Catherine Lozupone; Micah Hamady; Frederic D Bushman; Rob Knight
Journal:  Nucleic Acids Res       Date:  2007-09-18       Impact factor: 16.971

View more
  6 in total

1.  Metagenomic analysis of intestinal microbiota in wild rats living in urban and rural habitats.

Authors:  Rafig Gurbanov; Uygar Kabaoğlu; Tuba Yağcı
Journal:  Folia Microbiol (Praha)       Date:  2022-01-31       Impact factor: 2.099

2.  The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease.

Authors:  Kristel S Knudsen; Sverre Lehmann; Rune Nielsen; Solveig Tangedal; Ingvild Haaland; Pieter S Hiemstra; Tomas M Eagan
Journal:  PLoS One       Date:  2022-01-06       Impact factor: 3.240

3.  Metataxonomic investigation of the microbial community in the trachea and oropharynx of healthy controls and diabetic patients using endotracheal tubes.

Authors:  Sun Young Cho; Jeong-Hyun Choi; Seung Hyeun Lee; Yong-Sung Choi; Sung Wook Hwang; Young Jin Kim
Journal:  PLoS One       Date:  2021-11-05       Impact factor: 3.240

4.  An optimized approach for processing of frozen lung and lavage samples for microbiome studies.

Authors:  Rosana Wiscovitch-Russo; Harinder Singh; Lauren M Oldfield; Alexey V Fedulov; Norberto Gonzalez-Juarbe
Journal:  PLoS One       Date:  2022-04-05       Impact factor: 3.240

5.  Sonication versus the conventional method for evaluation of the dental microbiome: a prospective pilot study.

Authors:  Oliver Wagendorf; Peter Menzel; Rolf Schwarzer; Norbert Neckel; Saskia Preissner; Max Heiland; Susanne Nahles
Journal:  BMC Oral Health       Date:  2022-08-12       Impact factor: 3.747

6.  Lytic Bacteriophage PZL-Ah152 as Biocontrol Measures Against Lethal Aeromonas hydrophila Without Distorting Gut Microbiota.

Authors:  Chao Feng; Kaixiang Jia; Teng Chi; Shuaimin Chen; Huabo Yu; Liang Zhang; Sayed Haidar Abbas Raza; Ahmed Mohajja Alshammari; Shuang Liang; Zishan Zhu; Tingxuan Li; Yanling Qi; Xiaofeng Shan; Aidong Qian; Dongxing Zhang; Lei Zhang; Wuwen Sun
Journal:  Front Microbiol       Date:  2022-07-12       Impact factor: 6.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.